Arcellx (ACLX)

• Market cap: $3.93B
• 1 day: 1.63%
• 5 days: 0.47%
• 1 month: 9.62%
• 3 months: -22.87%
• 6 months: -3.74%
• Year to date: 7.4%
• 1 year: -0.31%
• 5 years: 304.94%
• 10 years: 304.94%
• Sector: Healthcare
• Industry: Biotechnology

About: Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Employees: 163